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Indirect Costs Associated with Surgery for Low
Back Pain—A Secondary Analysis of Clinical Trial Data
Reginald Fayssoux, M.D.,1 Neil I. Goldfarb,2 Alexander R. Vaccaro, M.D.,3 and James Harrop, M.D.3
Abstract
This study examines the indirect costs associated with surgery for axial low back pain using data obtained from
a prospective multicenter clinical trial that compared Charite´ artificial disc replacement with anterior lumbar
interbody fusion using iliac crest bone graft. While 75% of study subjects reported full- or part-time employment
prior to surgery, this percentage dropped to 45% at 6 weeks postoperatively. Return to preoperative employ-
ment levels occurred at approximately 6 months postoperatively. Two years after surgery, employment levels
were 16% higher than preoperative levels. Lost productivity related to absenteeism resulted in lost wages
averaging $2884 per patient during the first postoperative year. Although short-term indirect costs of surgery are
substantial from a societal perspective, the higher employment rate at 2 years suggests a long-term economic
benefit. The findings demonstrate the significant, though not surprising, impact of spinal disability on pro-
ductivity, and the importance of including measurement of lost productivity and return to work in the economic
evaluation of related interventions. (Population Health Management 2010;13:9–13)
Introduction
There is sparse literature regarding patients’ abil-ity to return to work following spinal surgery for axial
low back pain (LBP). Specifically, the time frame for return to
work, as well as factors associated with preoperative and
postoperative employment, are unknown. The indirect costs
associated with the postoperative recovery period for these
interventions also have not been determined. With health care
costs continuing to rise, economic considerations such as
these are becoming increasingly important in decisions re-
garding treatment alternatives and the allocation of health
care resources,1 especially in the care of the patient with back
pain.
The societal costs of back pain are dramatic. It has become
the second most common reason for a visit to a primary care
provider. Back pain is widely prevalent and afflicts 80% of
the population 60 years of age and older. The percentage of
patients with acute LBP who ultimately progress to chronic
LBP has been estimated to be anywhere from 2% to 34%.2 A
small subset of these patient may benefit from operative in-
tervention for back pain. In the workforce, lumbar back pain
remains one of the greatest contributors to health-related loss
of productivity. Previous estimates of health care expendi-
tures for LBP in the United States have been conservatively
estimated to be in excess of $90 billion per year.3
Chronic LBP, defined as longer than 3 months of symp-
toms, is generally regarded as having a poorer prognosis
than acute back pain.4 The sum of the literature suggests that
surgery for axial lumbar back pain can have successful out-
comes for carefully selected patients. A variety of procedures
aimed at alleviating chronic LBP without radiculopathy have
been utilized. In the setting of single-level degenerative disc
disease, the most common surgical treatment is fusion of the
involved spinal segments, though results are inconsistent.5
Due to technological advancements, a recent alternative is
total disc replacement surgery, though long-term data re-
garding efficacy are limited.6 Unfortunately, these recent
advancements in spine surgery have seen the introduction of
newer, more costly implants and procedures. The soaring
costs of spinal implants and biologic adjuncts to fusion have
resulted in increased scrutiny of the clinical and economic
impact of these interventions.
Costs related to an operative intervention can be divided
into direct costs (ie, costs associated with direct medical
treatment including surgery and postoperative monitoring)
and indirect costs (ie, costs associated with lost productivity
due to illness). Direct costs typically are viewed from either a
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provider (hospital and=or physician) or payer (insurer) per-
spective. From the provider perspective, direct costs include
costs related to the hospitalization including facility costs,
therapy costs, costs of diagnostic testing, and medical device
costs. Additional direct medical costs from the provider
perspective include the cost of the surgeon’s time. From the
payer perspective, direct costs include facility and physician
costs related to the hospitalization as well as costs related to
follow-up care and the management of postoperative com-
plications.
In contrast, indirect costs are more difficult to determine
and relate to lost workforce productivity resulting from ab-
sence at work (absenteeism) or decreased productivity at
work (presenteeism). Numerous studies have cited multiple
factors associated with return to work following an episode
of LBP that was treated nonoperatively.7–9 To our knowl-
edge, the time frame for return to work and factors associ-
ated with preoperative and postoperative employment
status following surgery for LBP have not been previously
described, nor has an estimate of the indirect costs related to
these procedures been previously published.
Recently, clinical trial data have become available from a
prospective multicenter study that compared the safety and
effectiveness of the Charite´ artificial lumbar disc to anterior
lumbar interbody fusion (ALIF) using threaded cages with
iliac crest bone graft (ICBG) for the treatment of single-level
degenerative disc disease at L4–L5 or L5–S1. Guyer and
colleagues10 analyzed this data comparing the direct costs of
the 2 procedures used in the clinical trial from both hospital
and payer perspectives. They found the overall economic
effect of 1-level total disc replacement on hospitals and
payers to be roughly equivalent to 1-level fusion.
From the provider=hospital perspective, the cost of oper-
ative intervention was $16,600 for the Charite´ artificial disc
and $18,600 for ALIF with ICBG. From a payer perspective,
direct costs were examined from 2 different points of view, a
Diagnosis Related Group (DRG) payment arm and a per
diem payment arm. The hospital costs from a DRG payment
arm perspective were $17,600 for the Charite´ artificial disc
and $33,000 for ALIF with ICBG. Costs from a per diem
payment arm perspective were $24,900 for the Charite´ arti-
ficial disc and $23,800 for ALIF with ICBG, though for con-
sistency these figures were based on 100% reimbursement of
spinal implant costs across all comparators in the study.
Regardless, the direct costs related to operative treatment of
single-level degenerative disc disease are significant.
In an effort to add to this discussion regarding the eco-
nomics of operative intervention for LBP, we analyzed the
clinical trial data comparing the Charite´ artificial disc and
ALIF with ICBG procedures to estimate the time frame for
and factors associated with return to work and to estimate
the indirect costs of surgery for LBP due to absenteeism.
Methods
We prospectively reviewed the clinical data from a non-
inferiority trial of 304 patients randomized in a 2:1 ratio to
receive either the Charite´ artificial disc replacement (205
patients) or ALIF with ICBG (99 patients). Inclusion and
exclusion criteria for this study were strict in an effort to
include only those patients with back pain, leg pain, or both
(but without radiculopathy) secondary to single-level de-
generative disc disease at L4–L5 or L5–S1, while minimizing
potentially confounding variables.11 These criteria have been
published previously.
Data included results of the Visual Analog Scale (VAS) for
pain, the Oswestry Disability Index (ODI), and the Short
Form (SF)-36 health survey recorded preoperatively, post-
operatively, at 6 weeks, and at 3, 6, 12, and 24 months after
surgery. The employment status of enrolled subjects was
categorized at these same time intervals as: full time, part
time, long-term disability leave, short-term disability leave,
unemployed, retired, and other (none of the above).
In order to better understand patient characteristics pre-
dicting return to work, a logistic regression model was
constructed. Several variables were screened for inclusion in
the model including sex, age, body mass index (BMI),
treatment received, baseline employment, normal activity
level, pain medication use, baseline and 24-month postop-
erative ODI score, baseline and 24-month postoperative VAS
score, and baseline and 24-month postoperative SF-36 score.
The variables were pared down using hierarchical elimina-
tion. The final model included sex, age, treatment, baseline
employment, and 24-month postoperative ODI and SF-36
Physical and Mental Health Composite scores. The adequacy
of this model was verified using the Hosmer Lemeshow
goodness-of-fit test.
Indirect costs related to absenteeism were estimated by
determining the level of productivity at each follow-up. In
order to better understand the economic impact of these
changes in productivity, the estimated earnings for patients
who underwent each procedure were calculated at each
follow-up. The average weekly salary for both treatment
groups was calculated using age-adjusted weekly salaries
based on national averages from the US Bureau of Labor
Statistics. These salaries were prorated for those who worked
part time. The average weekly salary was then calculated
overall and for both treatment groups at each follow-up.
Indirect costs related to absenteeism were estimated as the
wages lost as a result of absence from work.
Aggregate data was provided by Depuy Spine (DePuy
Spine, Inc., Raynham, MA). Institutional Review Board ap-
proval was received for this study. Data were analyzed using
Microsoft Excel 2002 (Microsoft Corporation, Redmond,
WA) and SPSS v16.0 statistical software package (SPSS Inc.,
Chicago, IL).
Results
Patient demographics for the study population are pre-
sented in Table 1. The average age of enrolled subjects was
39.6 years. The majority were white (>85%), and most sub-
jects were physically active (>85%). There were some minor
differences between groups with fusion patients having a
slightly higher degree of obesity, slightly more female sub-
jects, and slightly more minority patients. The overall mean
preoperative ODI, VAS, and SF-36 scores were equivalent
between groups (Table 2) and reflected significant disability.
We determined the number of subjects who worked full or
part time prior to surgery as a percentage of the entire study
population and also as a percentage of the study population
on payroll (ie, currently working or receiving employer paid
short-term and long-term disability). The percentage of the
entire study population who worked full or part time prior
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to surgery averaged 55% overall (53% for the Charite´ group
and 57% for the fusion group). The percentage of subjects on
payroll averaged 75% (75% for the Charite´ group and 77%
for the fusion group).
As would be expected, immediately after surgery there
was a substantial decrease in the number of subjects who
worked full or part time. However, at 6 weeks postopera-
tively, the percentage of the entire study population who
were working full or part time averaged 24% overall (26% for
the Charite´ group and 24% for the fusion group). The per-
centage of subjects on payroll who were working full or part
time averaged 40% (41% for the Charite´ group and 37% for
the fusion group). There was a gradual increase over the 2-
year follow-up period (Fig. 1). Stratification to include only
those subjects on payroll prior to surgery showed the Charite´
group tended to have a slightly higher percentage working
at each follow-up. Using a linear regression model, return to
baseline preoperative employment levels occurred approxi-
mately 6 months postoperatively for the entire study popu-
lation and for workers on payroll in both groups. At 24
months, the percentage of the entire study population who
were employed full or part time had increased 16% (ie, from
54.3% to 63.2%) when compared to the baseline preoperative
Table 1. Patient Demographics
Category Characteristic Charite´ % ALIF with ICBG %
Total 205 100.0% 99 100.0%
Age, categorical 18–24 7 3.4% 1 1.0%
25–44 142 69.3% 68 68.7%
45–64 56 27.3% 30 30.3%
65þ 0 0.0% 0 0.0%
Age, mean and SD 39.6 (8.16) 39.6 (9.07)
Sex male 113 55.1% 44 44.4%
female 92 44.9% 55 55.6%
Race white 188 91.7% 87 87.9%
black 8 3.9% 5 5.1%
Asian 0 0.0% 0 0.0%
Hispanic 0 0.0% 0 0.0%
other 9 4.4% 7 7.1%
Body mass index <18.5 4 2.0% 1 1.0%
18.6–24 83 40.5% 33 33.3%
25–29 83 40.5% 37 37.4%
>30 35 17.1% 28 28.3%
Concomitant diseases Anemia 7 3.4% 5 5.1%
Angina 2 1.0% 1 1.0%
Asthma 16 7.8% 9 9.1%
Cancer 2 1.0% 3 3.0%
COPD 2 1.0% 1 1.0%
Hepatitis 6 2.9% 6 6.1%
Hypertension 16 7.8% 14 14.1%
Liver disease 0 0.0% 2 2.0%
Osteoarthritis 11 5.4% 3 3.0%
Others 93 45.4% 41 41.4%
Peptic ulcer 7 3.4% 3 3.0%
Seizures 2 1.0% 2 2.0%
Type I diabetes 1 0.5% 1 1.0%
Type II diabetes 5 2.4% 2 2.0%
Urinary tract infection 5 2.4% 0 0.0%
Normal activity level prior to injury Active 188 91.7% 86 86.9%
Moderate 15 7.3% 11 11.1%
Light 1 0.5% 2 2.0%
Minimal 1 0.5% 0 0.0%
ALIF, anterior lumbar interbody fusion; COPD, chronic obstructive pulmonary disease; ICBG, iliac crest bone graft.
Table 2. Overall Mean Preoperative
Oswestry Disabiliy Index, Visual Analog Scale,
and Short Form-36 Scores
Charite´ Fusion
Oswestry Disability
Index (0 to 100%)
50.6 52.1
Visual Analog
Scale (0 to 100)
72.0 71.8
Short Form-36 Physical
Component Summary (0 to 100)
30.9 31.4
Short Form-36 Mental
Component Summary (0 to 100)
42.6 39.1
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employment rate. Likewise, at 24 months, the percentage of
subjects on payroll who were employed full or part time had
increased 3% (ie, from 72.4% to 74.8%) when compared to
the baseline preoperative employment rate.
Logistic regression analysis showed, not surprisingly, that
being employed at baseline was a strong predictor of return
to work; however, other baseline characteristics such as BMI,
pain medication use, or function as measured by ODI or SF-
36 were not significant independent predictors. Recovery at
24 months, as measured by ODI and SF-36 Mental Compo-
nent Summary (MCS) score, also was shown to be closely
associated with return to work (Table 3).
In order to better understand the economic impact of the
changes in productivity, the estimated earnings for patients
who underwent each procedure were calculated at each
follow-up using US Bureau of Labor Statistics data (Fig. 1).
The average weekly salary for full-time workers was esti-
mated to be $728 overall, $725 for the Charite´ group, and
$735 for the fusion group. In general, weekly salaries were
greater in the Charite´ group than the fusion group at each
follow-up, despite the lower estimated earning potential in
the Charite´ group. Lost productivity related to absentee-
ism for this study population resulted in costs to society
averaging $2884 per patient in the first year following
surgery.
Discussion
We analyzed prospectively collected data from a multi-
center trial that compared Charite´ with fusion in order to
establish the time frame for return to work and factors
associated with preoperative and postoperative employ-
ment status, and to estimate the indirect costs of surgery for
LBP related to absenteeism. We found only 75% of subjects
on payroll (ie, currently working or receiving employer
paid short- or long-term disability) were working full or
part time prior to surgery. A significant drop occurred in
the percentage of patients reporting full- or part-time em-
ployment 6 weeks after surgery, with a gradual increase
over the following 2 years. Return to preoperative pro-
ductivity levels occurred between 6 and 12 months post-
operatively. Two years postoperatively the employment
status had increased approximately 16%. Given the delay in
return to productivity related to absenteeism, the short-term
indirect costs from a societal perspective are substantial;
however, the higher employment status at 2 years suggests
a long-term benefit. Further research in this regard is
needed.
The low preoperative employment rate of patients is not
surprising given that nearly 80% of patients had preopera-
tive ODIs of 40% or greater, values associated with severe
disability. The delay in return to preoperative productivity
levels likely resulted from the postoperative rehabilitation
associated with anterior lumbar spine surgery. The relatively
lower success rate of operative treatment of isolated axial
back pain certainly played a role as well. This delay in pro-
ductivity resulted in significant costs in the short term.
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FIG. 1. Percentage of patients working during each follow-up period.
Table 3. Logistic Regression Results for Prediction
of Return to Work
Parameter Estimate
Standard
error P-Value
Intercept 1.0459 1.3467 0.4374
Gender 0.199 0.1808 0.2712
Age 0.018 0.0204 0.3779
Treatment 0.2801 0.2004 0.1622
Baseline employment 1.0615 0.1845 <.0001
24-month ODI 0.0449 0.0105 <.0001
24-month mental component
summary
0.035 0.0174 0.0448
ODI, Oswestry Disability Index.
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Logistic regression analysis showed that, of the limited
number of candidate predictive variables that were available
for this analysis, few were predictive of return to work.
Baseline employment status, improvement in functional
status as measured by the ODI, and improvement in MCS on
the SF-36 were associated with return to work. While this
finding is largely intuitive, it does suggest that postsurgical
interventions, such as physical and occupational therapy,
may hasten return to work, although clearly this conclusion
is speculative.
The indirect costs related to absenteeism of surgery for
LBP in this study population were $2,884 per patient during
the first postoperative year. The majority of these indirect
costs were related to absenteeism in the first several post-
operative months as employment rates reached baseline at
approximately 6 months postoperatively. Currently, data
regarding indirect costs of spinal surgery are lacking. As
economic considerations become an increasingly important
issue, cost effectiveness evaluations will find increasing im-
portance in the surgical literature of the spine. This article
adds to the literature a rough measure of the indirect costs
associated with spine surgery for LBP.
This article has several limitations. The full analysis of
indirect costs requires consideration of costs related to pre-
senteeism. Unfortunately, there were no data to allow for this
determination. Additionally, the criteria for inclusion into the
clinical trial were fairly strict in an effort to include only
subjects with single-level degenerative disc disease without
radiculopathy, while limiting confounding factors. These
strict criteria may have resulted in an overestimation of in-
direct costs because subjects in this clinical trial had rela-
tively severe disease. Finally, because actual salary data were
not collected in the clinical trial, the estimation of average
weekly salaries was based on age-adjusted data from the US
Bureau of Labor Statistics. Therefore, the information on lost
productivity costs presented here is a crude estimate; how-
ever, the findings do demonstrate the importance of includ-
ing productivity measures in cost-effectiveness evaluations
of LBP interventions.
In conclusion, a significant drop in employment follows
surgery for axial LBP with either procedure; this may per-
sist for close to 1 year postoperatively. By 2 years post
surgery, employment rates increased to levels that exceeded
those prior to surgery. Return to work after surgery may be
predicted by preoperative employment status and ODI and
SF-36 MCS outcomes at 24-months follow-up. The indirect
costs related to absenteeism as a result of surgery for LBP
are substantial, averaging just over $2800 per patient during
the first postoperative year with the majority of the loss
incurred in the first several months following surgery.
These findings demonstrate the significant, though not
surprising, impact of spinal disability on productivity, and
the importance of including the measurement of lost pro-
ductivity and return to work in the effectiveness and cost-
effectiveness evaluation of operative (and nonoperative)
interventions.
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